SEMINAR: �Antisense oligomer therapies for neuromuscular disorders�
|
|
Sue Fletcher completed her first degree at the University of Zimbabwe (when the country still had a functional education system) and a PhD at UWA. She is a Principal Research Fellow working with Steve Wilton on developing antisense therapies for inherited disorders at the Centre for Neuromuscular and Neurological Disorders, University of Western Australia. The Wilton laboratory is located within the Australian Neuromuscular Research Institute, which is also the home of Muscular Dystrophy Western Australia. This group pioneered antisense oligomer induced exon skipping to overcome dystrophin mutations, and have developed antisense oligos for every dystrophin exon, except the first and last. Although not all dystrophin mutations are amenable to exon skipping intervention, and the potential improvements will depend upon the nature and location of the mutation, oligomer strategies should be developed for all, not just those with common mutations. The group are now exploring ways to overcome DMD-causing non-deletion mutations, including duplications and extending the technology to other inherited neuromuscular disorders, including spinal muscular atrophy.
Speaker(s) |
Susan Fletcher
|
Location |
Bruce Hunt Lecture Theatre, Level 2 South Block, Royal Perth Hospital (Enter South Block directly from Wellington Street, at street level, and the theatre is on your immediate right.)
|
|
Contact |
Fiona Mackenzie
<[email protected]>
: 93463838
|
URL |
http://www.waimr.uwa.edu.au
|
Start |
Wed, 24 Oct 2012 16:00
|
End |
Wed, 24 Oct 2012 17:00
|
Submitted by |
Fiona Mackenzie <[email protected]>
|
Last Updated |
Fri, 19 Oct 2012 14:30
|
Included in the following Calendars: |
|
- Locations of venues on the Crawley and Nedlands campuses are
available via the Campus Maps website.
- Download this event as:
Text |
iCalendar
-
Mail this event:
|